North China Pharmaceutical Company Ltd. (600812.SS) SHH

6.70

+0.1(+1.52%)

Updated at August 19 11:29AM

Currency In CNY

Valuation

Market Cap8.87B
Enterprise Value18.03B
P/E Ratio68.52
PEG Ratio2.17
Price/Sales Ratio1.11
Price/Book Ratio2.09
Enterprise/Revenue1.99
Enterprise/EBITDA19.84

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.02
Operating Margin0.04

Management Effectiveness

Return On Assets0.01
Return On Equity0.03

Income Statement

Revenue9.87B
Revenue/Share5.83
Gross Profit3.15B
EBITDA1.63B
Net Income126.99M
Diluted EPS0.07

Balance Sheet

Total Cash2B
Total Cash/Share1.9
Total Debt10.63B
Total Debt/Equity1.95
Current Ratio0.73
Book Value Per Share3.99

Price History

52-Week Change35.07
52-Week High7.46
52-Week Low4.41
Moving Average 50 Days6.56
Moving Average 200 Days6.05

Statistics

Average Volume26.4M
Shares Outstanding1.63B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.03
Trailing Annual Dividend Yield0.45
Payout Ratio2.53
Last Split Factor196:125
Last Split DateAugust 15, 2006